Organization | ProMedica Health System

ProMedica Health System Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Toledo OH United States (1986)

Organization Overview

First Clinical Trial

2009

NCT00985361

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Gregory Georgiadis | ProMedica Health System

Active Ingredients

Drugs in Phase 4 Trials (3)

ethyl chloride (1 trial)

glucomannan (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Phase 3 Trials (1)

clevidipine (cleviprex) (1 trial)

Drugs in Phase 2 Trials (1)

cetylpyridinium chloride (1 trial)

Drugs in Other Trials (5)

acetaminophen (tylenol) (1 trial)

oxycodone (oxycontin) (1 trial)

recombinant salmon calcitonin (rsct) (1 trial)

vitamin c (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Pain (Phase 4)

Hip Fractures (Phase 4)

Overweight (Phase 4)

Respiratory Tract Infections (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 10